KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Intangibles: 2009-2019

Historic Intangibles for Arbutus Biopharma (ABUS) over the last 4 years, with Jun 2019 value amounting to $43.8 million.

  • Arbutus Biopharma's Intangibles fell 25.25% to $43.8 million in Q2 2019 from the same period last year, while for Jun 2019 it was $43.8 million, marking a year-over-year decrease of 25.25%. This contributed to the annual value of $43.8 million for FY2018, which is 25.25% down from last year.
  • Arbutus Biopharma's Intangibles amounted to $43.8 million in Q2 2019, which was down 0.00% from $43.8 million recorded in Q1 2019.
  • Over the past 5 years, Arbutus Biopharma's Intangibles peaked at $390.0 million during Q2 2015, and registered a low of $43.8 million during Q3 2018.
  • Moreover, its 3-year median value for Intangibles was $58.6 million (2018), whereas its average is $65.0 million.
  • Data for Arbutus Biopharma's Intangibles shows a maximum YoY plummeted of 71.80% (in 2016) over the last 5 years.
  • Quarterly analysis of 5 years shows Arbutus Biopharma's Intangibles stood at $352.6 million in 2015, then plummeted by 71.80% to $99.4 million in 2016, then slumped by 41.03% to $58.6 million in 2017, then fell by 25.25% to $43.8 million in 2018, then decreased by 25.25% to $43.8 million in 2019.
  • Its Intangibles was $43.8 million in Q2 2019, compared to $43.8 million in Q1 2019 and $43.8 million in Q4 2018.